Research programme: Marburg virus DNA vaccine - Cyto Pulse/USAMRIID
Latest Information Update: 16 Jul 2016
At a glance
- Originator Cyto Pulse Sciences; United States Army Medical Research Institute of Infectious Diseases
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Marburg virus disease
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Marburg virus disease in USA